Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients infected with the human immunodeficiency virus. Public Health Service Task Force on Prophylaxis and Therapy for Mycobacterium avium Complex.
National Institutes of Health, Bethesda, MD 20892.
H
H
Masur
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D006801:Humans; D007223:Infant; D008826:Microbial Sensitivity Tests; D015269:Mycobacterium avium Complex / Q000302:isolation & purification; D015270:Mycobacterium avium-intracellulare Infection / Q000175:diagnosis / Q000517:prevention & control* / Q000628:therapy; D017828:Rifabutin; D012294:Rifamycins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D012294:Rifamycins; D017828:Rifabutin